✦ LIBER ✦

Long Term Outcomes of Autologous Hematopoietic Cell Transplant (AHCT) Following Thiotepa-Based High-Dose Therapy (HDT) in Patients with Non-Hodgkin Lymphoma (NHL)

✍ Scribed by Shah, Nilay A.; Rauenzahn, Sherri; Wen, Sijin; Craig, Michael; Kanate, Abraham S.; Hamadani, Mehdi; Cumpston, Aaron

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term clinical and molecular remissi

✍ Metzner, Bernd; Müller, Thomas H.; Gebauer, Wolfgang; Casper, Jochen; Kraemer, D 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 208 KB

Long-Term Follow-Up of Patients with Non

✍ Mathias Witzens-Harig; Conny Heilmann; Manfred Hensel; Martin Kornacker; Axel Be 📂 Article 📅 2007 🏛 AlphaMed Press 🌐 English ⚖ 331 KB

High Dose Therapy and Autologous Stem Ce

✍ Tamari, Roni; Dahi, Parastoo; Devlin, Sean; Goldberg, Jenna; Paul, Paul Hamlin; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Transplanted CD34+ Cell Dose Is Associat

✍ Patrick J. Stiff; Ivana Micallef; Auayporn P. Nademanee; Edward A. Stadtmauer; R 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Long-term followup of health status in p

✍ Y. K. O. Teng; R. J. Verburg; J. K. Sont; W. B. Van Den Hout; F. C. Breedveld; J 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

Long-Term Follow-Up of Tandem High-Dose

✍ Hélène Monjanel; Eric Deconinck; Elodie Perrodeau; Thomas Gastinne; Vincent Delw 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 321 KB